Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This reprint is a compilation of nine papers published in Processes, in a Special Issue on “Modeling and Simulation of Polymerization Processes”. It aimed to address both new findings on basic topics and the modeling of the emerging aspects of product design and polymerization processes. It provides a nice view of the state of the art with regard to the modeling and simulation of polymerization processes. The use of well-established methods (e.g., the method of moments) and relatively more recent modeling approaches (e.g., Monte Carlo stochastic modeling) to describe polymerization processes of long-standing interest in industry (e.g., rubber emulsion polymerization) to polymerization systems of more modern interest (e.g., RDRP and plastic pyrolysis processes) are comprehensively covered in the papers contained in this reprint.

Technology: general issues --- Chemical engineering --- dithiolactones --- RAFT polymerization --- kinetic modeling --- vinyl monomers --- methyl methacrylate --- polystyrene --- thermal pyrolysis --- nitroxide mediated polymerization --- mathematical modeling --- Poly(acrylic acid) --- free-radical polymerization --- reaction model --- process intensification --- semi-batch to continuous --- initiator feeding policies --- styrene --- Monte Carlo simulation --- polymer microstructure --- aqueous phase polymerization --- polyelectrolytes --- radical polymerization --- modeling and simulation --- emulsion polymerization --- styrene-butadiene rubber --- nitrile rubber --- ethylene polymerization --- metallocene --- zirconium-based catalyst --- organoboron compounds --- polymer grafting --- polymer synthesis --- polymer characterization --- polymer reaction engineering --- reversible deactivation radical polymerization --- nano-SiO2 --- silane coupling agent --- thermal stability --- mechanical parameter --- molecular simulation --- dithiolactones --- RAFT polymerization --- kinetic modeling --- vinyl monomers --- methyl methacrylate --- polystyrene --- thermal pyrolysis --- nitroxide mediated polymerization --- mathematical modeling --- Poly(acrylic acid) --- free-radical polymerization --- reaction model --- process intensification --- semi-batch to continuous --- initiator feeding policies --- styrene --- Monte Carlo simulation --- polymer microstructure --- aqueous phase polymerization --- polyelectrolytes --- radical polymerization --- modeling and simulation --- emulsion polymerization --- styrene-butadiene rubber --- nitrile rubber --- ethylene polymerization --- metallocene --- zirconium-based catalyst --- organoboron compounds --- polymer grafting --- polymer synthesis --- polymer characterization --- polymer reaction engineering --- reversible deactivation radical polymerization --- nano-SiO2 --- silane coupling agent --- thermal stability --- mechanical parameter --- molecular simulation

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue on “Polymer Membranes for Gas Separation” of the journal Membranes aims to offer an overview about the different applications and strategies available to improve the separation performances based on the material choice and the process conditions.Various topics have been discussed, including the synthesis and characterization of novel membrane materials, membrane aging, and the impact of process conditions on transport phenomena.

Technology: general issues --- Chemical engineering --- gas separation --- CO2 capture --- mixed-matrix membranes --- aromatic poly(imide)s --- bulky pendant groups --- gas permeability --- structure-property relationship --- polyphenylacetylene --- cis-cisoid conformation --- cis-transoid conformation --- carbamate group --- membrane-forming ability --- solubility --- oxygen permeation membrane --- graphdiyne --- molecular simulation --- membrane separation --- hydrogen purification --- polyimide membrane --- natural gas separation --- pollutant effects --- stability measurements --- facilitated transport --- fixed site carrier membrane --- polyallylamine-polyvinyl alcohol-graphene oxide membrane --- modelling --- carbon capture --- gas permeation --- composite membranes --- CO2/CH4 separation --- water and organic pollutants --- hydrophilic/hydrophobic character --- biogas upgrading --- sustainable energy --- electrochemical hydrogen separation --- electrochemical hydrogen pump --- proton exchange membrane (PEM) --- hydrogen purification/separation --- physical aging --- hyper cross-linked polymer --- 13C spin-lattice relaxation times --- SS-NMR spectroscopy --- n/a

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Polymer composite materials have attracted great interest for the development of electrical and electronic engineering and technology, and have been widely applied in electrical power systems, electrical insulation equipment, electrical and electronic devices, etc. Due to the significant expansion in the use of newly developed polymer composite materials, it is necessary to understand and accurately describe the relationship between composite structure and material properties, as only based on thorough laboratory characterization is it possible to estimate the properties for their future commercial applications. This book focuses on polymer composites applied in the field of electrical and electronic equipment, including but not limited to synthesis and preparation of new polymeric materials, structure–properties relationship of polymer composites, evaluation of materials application, simulation and modelling of material performance.

aramid nanofiber --- hydrogen bonds --- electric breakdown strength --- mechanical strength --- alumina nanoplates --- SiC crystal form --- micro-nano compound --- thermal conductivity --- breakdown field strength --- space charge --- polyimide polymer --- unipolar electrical stress --- temperature --- frequency --- surface streamer discharge --- silicone rubber coating --- three-electrode arrangement --- thermally stimulated current method --- surface properties --- dielectric elastomer --- intrinsic property --- energy harvesting --- epoxy resins --- Langmuir --- terahertz --- molecular simulation --- prediction --- epoxy resin --- partial discharge --- active product --- electro-thermal dissociation --- reactive molecular dynamics --- polyimide --- graphitic carbon nitride nanosheets --- polydopamine --- interfacial interaction --- breakdown strength --- molecular dynamics simulation --- damping performance --- nitrile-butadiene rubber --- graphene oxide --- antioxidant 4010NA --- droplet vibration --- high voltage insulator --- polymeric surface --- corona discharge --- arcing --- creepage distance --- streamer discharge --- curved profiles --- streamer propagation “stability” field --- streamer propagation path --- streamer propagation velocity --- Eucommia ulmoides gum --- carbon nanotubes --- graphene --- electromagnetic shielding --- honeycomb sandwich composites --- metamaterial --- radar stealth --- microwave absorbing material --- low frequency

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book is a printed edition of the Special Issue entitled “Anticancer Agents: Design, Synthesis and Evaluation” that was published in Molecules. Two review articles and thirty research papers are included in the Special Issue. Three second-generation androgen receptor antagonists that have been approved by the U.S. FDA for the treatment of prostate cancer have been reviewed. Identification of mimics of protein partners as protein-protein interaction inhibitors via virtual screening has been summarized and discussed. Anticancer agents targeting various protein targets, including IGF-1R, Src, protein kinase, aromatase, HDAC, PARP, Toll-Like receptor, c-Met, PI3Kdelta, topoisomerase II, p53, and indoleamine 2,3-dioxygenase, have been explored. The analogs of three well-known tubulin-interacting natural products, paclitaxel, zampanolide, and colchicine, have been designed, synthesized, and evaluated. Several anticancer agents representing diverse chemical scaffolds were assessed in different kinds of cancer cell models. The capability of some anticancer agents to overcome the resistance to currently available drugs was also studied. In addition to looking into the in vitro ability of the anticancer agents to inhibit cancer cell proliferation, apoptosis, and cell cycle, in vivo antitumor efficacy in animal models and DFT were also investigated in some papers.

Medicine --- benzofurans --- chemical synthesis --- cytotoxic properties --- HeLa --- MOLT-4 --- K562 --- anticancer --- anti-neuroinflammation --- coumarin --- dihydroartemisinin --- flavonoids --- allene --- E-stereoselective --- regioselective --- anti-cancer activity --- cyanopyridone --- substituted pyridine --- pyridotriazine --- pyrazolopyridine --- thioxotriazopyridine --- anticancer activity --- HepG2 --- antitumor activity --- computational docking --- MDM2-p53 interaction --- xanthones --- yeast-based assays --- estrone derivatives --- hydrazine --- N-substituted pyrazoline --- anti-ovarian cancer --- topoisomerase II inhibitor --- kinase inhibitor --- antiproliferative agent --- urea --- synthesis --- antiproliferative activity --- apoptosis --- indoleamine 2,3-dioxygenase --- inhibitor --- anti-tumor --- immune modulation --- tryptophan metabolism --- taxoids --- βIII-tubulin --- P-glycoprotein --- drug resistance --- thiopene --- thienopyrimidinone --- thiazolidinone --- breast cancer --- benzofuran–pyrazole --- nanoparticles --- cytotoxic activity --- PARP-1 inhibition --- 3,6-dibromocarbazole --- 5-bromoindole --- carbazole --- actin --- migration --- Thienopyrimidine --- Pyrazole --- PI3Kα inhibitor --- quinazolin-4(3H)-one --- quinazolin-4(3H)-thione --- Schiff base --- antioxidant activity --- DFT study --- ortho-quinones --- beta-lapachone --- tanshione IIA --- PI3Ks --- PI3Kδ inhibitors --- 2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide --- anticancer agents --- protein–protein interactions --- virtual screening --- mimetics --- drug discovery --- bivalency --- polyvalency --- antitumor --- cell cycle --- ovarian cancer --- P-MAPA --- IL-12 --- TLR signaling --- inflammation --- chemoresistance --- 4-(pyridin-4-yloxy)benzamide --- 1,2,3-triazole --- c-Met --- natural product --- anticancer agent --- zampanolide --- Talazoparib --- PARP inhibitor --- prodrug --- o-nitro-benzyl --- photoactivatable protecting groups --- salinomycin --- overcoming drug resistance --- tumor specificity --- synergy --- 5-fluorouracil --- gemcitabine --- amides/esters --- colchicine analogs --- thiocolchicine --- colchiceine --- antimitotic agents --- hydrates --- dihydropyranoindole --- HDAC inhibitors --- neuroblastoma --- aromatase --- MCF-7 --- NIH3T3 --- benzimidazole --- triazolothiadiazine --- docking --- ADME --- organosilicon compounds --- SILA-409 (Alis-409) --- SILA-421 (Alis-421) --- multidrug resistance (MDR) reversal --- ABCB1 (P-glycoprotein) --- colon cancer --- colchicine amide --- colchicine sulfonamide --- tubulin inhibitors --- docking studies --- crystal structure --- PROTACs --- protein degradation --- IGF-1R --- Src --- protein kinase --- phenylpyrazolopyrimidine --- enzyme inhibition --- molecular simulation --- androgen receptor --- prostate cancer --- enzalutamide --- apalutamide --- darolutamide --- triple-negative breast cancer --- cytotoxicity --- chrysin analogues --- flavonoid --- anticancer compounds --- benzofurans --- chemical synthesis --- cytotoxic properties --- HeLa --- MOLT-4 --- K562 --- anticancer --- anti-neuroinflammation --- coumarin --- dihydroartemisinin --- flavonoids --- allene --- E-stereoselective --- regioselective --- anti-cancer activity --- cyanopyridone --- substituted pyridine --- pyridotriazine --- pyrazolopyridine --- thioxotriazopyridine --- anticancer activity --- HepG2 --- antitumor activity --- computational docking --- MDM2-p53 interaction --- xanthones --- yeast-based assays --- estrone derivatives --- hydrazine --- N-substituted pyrazoline --- anti-ovarian cancer --- topoisomerase II inhibitor --- kinase inhibitor --- antiproliferative agent --- urea --- synthesis --- antiproliferative activity --- apoptosis --- indoleamine 2,3-dioxygenase --- inhibitor --- anti-tumor --- immune modulation --- tryptophan metabolism --- taxoids --- βIII-tubulin --- P-glycoprotein --- drug resistance --- thiopene --- thienopyrimidinone --- thiazolidinone --- breast cancer --- benzofuran–pyrazole --- nanoparticles --- cytotoxic activity --- PARP-1 inhibition --- 3,6-dibromocarbazole --- 5-bromoindole --- carbazole --- actin --- migration --- Thienopyrimidine --- Pyrazole --- PI3Kα inhibitor --- quinazolin-4(3H)-one --- quinazolin-4(3H)-thione --- Schiff base --- antioxidant activity --- DFT study --- ortho-quinones --- beta-lapachone --- tanshione IIA --- PI3Ks --- PI3Kδ inhibitors --- 2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide --- anticancer agents --- protein–protein interactions --- virtual screening --- mimetics --- drug discovery --- bivalency --- polyvalency --- antitumor --- cell cycle --- ovarian cancer --- P-MAPA --- IL-12 --- TLR signaling --- inflammation --- chemoresistance --- 4-(pyridin-4-yloxy)benzamide --- 1,2,3-triazole --- c-Met --- natural product --- anticancer agent --- zampanolide --- Talazoparib --- PARP inhibitor --- prodrug --- o-nitro-benzyl --- photoactivatable protecting groups --- salinomycin --- overcoming drug resistance --- tumor specificity --- synergy --- 5-fluorouracil --- gemcitabine --- amides/esters --- colchicine analogs --- thiocolchicine --- colchiceine --- antimitotic agents --- hydrates --- dihydropyranoindole --- HDAC inhibitors --- neuroblastoma --- aromatase --- MCF-7 --- NIH3T3 --- benzimidazole --- triazolothiadiazine --- docking --- ADME --- organosilicon compounds --- SILA-409 (Alis-409) --- SILA-421 (Alis-421) --- multidrug resistance (MDR) reversal --- ABCB1 (P-glycoprotein) --- colon cancer --- colchicine amide --- colchicine sulfonamide --- tubulin inhibitors --- docking studies --- crystal structure --- PROTACs --- protein degradation --- IGF-1R --- Src --- protein kinase --- phenylpyrazolopyrimidine --- enzyme inhibition --- molecular simulation --- androgen receptor --- prostate cancer --- enzalutamide --- apalutamide --- darolutamide --- triple-negative breast cancer --- cytotoxicity --- chrysin analogues --- flavonoid --- anticancer compounds

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book is a printed edition of the Special Issue entitled “Anticancer Agents: Design, Synthesis and Evaluation” that was published in Molecules. Two review articles and thirty research papers are included in the Special Issue. Three second-generation androgen receptor antagonists that have been approved by the U.S. FDA for the treatment of prostate cancer have been reviewed. Identification of mimics of protein partners as protein-protein interaction inhibitors via virtual screening has been summarized and discussed. Anticancer agents targeting various protein targets, including IGF-1R, Src, protein kinase, aromatase, HDAC, PARP, Toll-Like receptor, c-Met, PI3Kdelta, topoisomerase II, p53, and indoleamine 2,3-dioxygenase, have been explored. The analogs of three well-known tubulin-interacting natural products, paclitaxel, zampanolide, and colchicine, have been designed, synthesized, and evaluated. Several anticancer agents representing diverse chemical scaffolds were assessed in different kinds of cancer cell models. The capability of some anticancer agents to overcome the resistance to currently available drugs was also studied. In addition to looking into the in vitro ability of the anticancer agents to inhibit cancer cell proliferation, apoptosis, and cell cycle, in vivo antitumor efficacy in animal models and DFT were also investigated in some papers.

benzofurans --- chemical synthesis --- cytotoxic properties --- HeLa --- MOLT-4 --- K562 --- anticancer --- anti-neuroinflammation --- coumarin --- dihydroartemisinin --- flavonoids --- allene --- E-stereoselective --- regioselective --- anti-cancer activity --- cyanopyridone --- substituted pyridine --- pyridotriazine --- pyrazolopyridine --- thioxotriazopyridine --- anticancer activity --- HepG2 --- antitumor activity --- computational docking --- MDM2-p53 interaction --- xanthones --- yeast-based assays --- estrone derivatives --- hydrazine --- N-substituted pyrazoline --- anti-ovarian cancer --- topoisomerase II inhibitor --- kinase inhibitor --- antiproliferative agent --- urea --- synthesis --- antiproliferative activity --- apoptosis --- indoleamine 2,3-dioxygenase --- inhibitor --- anti-tumor --- immune modulation --- tryptophan metabolism --- taxoids --- βIII-tubulin --- P-glycoprotein --- drug resistance --- thiopene --- thienopyrimidinone --- thiazolidinone --- breast cancer --- benzofuran–pyrazole --- nanoparticles --- cytotoxic activity --- PARP-1 inhibition --- 3,6-dibromocarbazole --- 5-bromoindole --- carbazole --- actin --- migration --- Thienopyrimidine --- Pyrazole --- PI3Kα inhibitor --- quinazolin-4(3H)-one --- quinazolin-4(3H)-thione --- Schiff base --- antioxidant activity --- DFT study --- ortho-quinones --- beta-lapachone --- tanshione IIA --- PI3Ks --- PI3Kδ inhibitors --- 2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide --- anticancer agents --- protein–protein interactions --- virtual screening --- mimetics --- drug discovery --- bivalency --- polyvalency --- antitumor --- cell cycle --- ovarian cancer --- P-MAPA --- IL-12 --- TLR signaling --- inflammation --- chemoresistance --- 4-(pyridin-4-yloxy)benzamide --- 1,2,3-triazole --- c-Met --- natural product --- anticancer agent --- zampanolide --- Talazoparib --- PARP inhibitor --- prodrug --- o-nitro-benzyl --- photoactivatable protecting groups --- salinomycin --- overcoming drug resistance --- tumor specificity --- synergy --- 5-fluorouracil --- gemcitabine --- amides/esters --- colchicine analogs --- thiocolchicine --- colchiceine --- antimitotic agents --- hydrates --- dihydropyranoindole --- HDAC inhibitors --- neuroblastoma --- aromatase --- MCF-7 --- NIH3T3 --- benzimidazole --- triazolothiadiazine --- docking --- ADME --- organosilicon compounds --- SILA-409 (Alis-409) --- SILA-421 (Alis-421) --- multidrug resistance (MDR) reversal --- ABCB1 (P-glycoprotein) --- colon cancer --- colchicine amide --- colchicine sulfonamide --- tubulin inhibitors --- docking studies --- crystal structure --- PROTACs --- protein degradation --- IGF-1R --- Src --- protein kinase --- phenylpyrazolopyrimidine --- enzyme inhibition --- molecular simulation --- androgen receptor --- prostate cancer --- enzalutamide --- apalutamide --- darolutamide --- triple-negative breast cancer --- cytotoxicity --- chrysin analogues --- flavonoid --- anticancer compounds